← Back to Patent Explorer
US4801619A Expired / Lapsed US ⏱️ 0.0 years remaining

Hyaluronic acid preparation to be used for treating inflammations of skeletal joints

Assignee: Pfizer Health AB
•
Filing: 1986-04-02
•
Granted: 1989-01-31
•
Expires: 2006-04-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Hyaluronic acid preparation containing an effective amount of hyaluronic acid of a molecular weight exceeding 3×10 6 dalton, for intra-articular administration in the treatment of steroid arthropathy and progressive cartilage degeneration caused by proteoglycan degradation.

Inventors

  • 👤 Gert T. Lindblad

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 02:30
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/715; A61K31/726; A61K31/728

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 42 words
A method for the treatment of a joint undergoing progressive cartilage degeneration caused by proteoglycan degradation, comprising administering intra-articularly to the said joint a hyaluronic acid preparation containing an effective amount of hyaluronic acid of a molecular weight exceeding 4×10 6 dalton.
Claim 2
Independent Claim 42 words
A method for the treatment of a joint undergoing progressive cartilage degeneration caused by proteoglycan degradation, comprising administering intra-articularly to the said joint a hyaluronic acid preparation containing an effective amount of hyaluronic acid of a molecular weight exceeding 4×10 6 dalton.
Claim 3
Independent Claim 36 words
A method for preventing steroid arthropathy of a human joint, comprising administering intra-articularly to the said joint a hyaluronic acid preparation containing an effective amount of hyaluronic acid of a molecular weight exceeding 4×10 6 dalton.
Claim 4
Independent Claim 36 words
A method for preventing steroid arthropathy of a human joint, comprising administering intra-articularly to the said joint a hyaluronic acid preparation containing an effective amount of hyaluronic acid of a molecular weight exceeding 4×10 6 dalton.

References Cited (Backward Citations)

US3396081A Cited
US4141973A Cited
US4141973B1 Cited
US4328803A Cited
US4328803B1 Cited
US4517295A Cited
EP0138572A2 Cited
EP0143393A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-01-31 1992-08-01 1993-01-31 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-01-31 1996-08-01 1997-01-31 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-01-31 2000-08-01 2001-01-31 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag